Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Rizzetto

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
Expert Opinion on Drug Safety|September 5, 2012
Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studiesPatrick Marcellin, Stuart K Roberts, K Rajender Reddy, et al.
International Journal of Colorectal Disease|July 26, 2008
Identification of a new WASP and FKBP-like (WAFL) protein in inflammatory bowel disease: a potential marker gene for ulcerative colitisIng-Marie Viklund, Nikolai V Kuznetsov, Robert Löfberg, et al.
Journal of Clinical Gastroenterology|September 19, 2013
Unexplained common bile duct dilatation with normal serum liver enzymes: diagnostic yield of endoscopic ultrasound and follow-up of this conditionMauro Bruno, Rosario F Brizzi, Lavinia Mezzabotta, et al.
Journal of Advanced Research|October 4, 2021
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished diseaseGian Paolo Caviglia, Silvia Martini, Alessia Ciancio, et al.
Panminerva Medica|June 27, 2017
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-IIGian P Caviglia, Maria L Abate, Silvia Gaia, et al.
Antiviral Research|August 13, 2013
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patientsAntonio D'Avolio, Amedeo De Nicolò, Jessica Cusato, et al.
The American Journal of Gastroenterology|August 16, 2008
Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort studyChiara Giordanino, Elisabetta Bugianesi, Antonina Smedile, et al.
Biomedicines|April 23, 2022
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus QuantificationAntonella Olivero, Chiara Rosso, Alessia Ciancio, et al.
Gut and Liver|September 20, 2011
Safety and efficacy of endoscopic retrograde cholangiopancreatography in patients with post-liver transplant biliary complications: results of a cohort study with long-term follow-upClaudia Sanna, Chiara Giordanino, Ilaria Giono, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis deltaGrazia Anna Niro, Alessia Ciancio, Giovanni Battista Gaeta, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
Expert Opinion on Drug Safety|September 5, 2012
Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studiesPatrick Marcellin, Stuart K Roberts, K Rajender Reddy, et al.
International Journal of Colorectal Disease|July 26, 2008
Identification of a new WASP and FKBP-like (WAFL) protein in inflammatory bowel disease: a potential marker gene for ulcerative colitisIng-Marie Viklund, Nikolai V Kuznetsov, Robert Löfberg, et al.
Journal of Clinical Gastroenterology|September 19, 2013
Unexplained common bile duct dilatation with normal serum liver enzymes: diagnostic yield of endoscopic ultrasound and follow-up of this conditionMauro Bruno, Rosario F Brizzi, Lavinia Mezzabotta, et al.
Journal of Advanced Research|October 4, 2021
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished diseaseGian Paolo Caviglia, Silvia Martini, Alessia Ciancio, et al.
Panminerva Medica|June 27, 2017
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-IIGian P Caviglia, Maria L Abate, Silvia Gaia, et al.
Antiviral Research|August 13, 2013
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patientsAntonio D'Avolio, Amedeo De Nicolò, Jessica Cusato, et al.
The American Journal of Gastroenterology|August 16, 2008
Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort studyChiara Giordanino, Elisabetta Bugianesi, Antonina Smedile, et al.
Biomedicines|April 23, 2022
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus QuantificationAntonella Olivero, Chiara Rosso, Alessia Ciancio, et al.
Gut and Liver|September 20, 2011
Safety and efficacy of endoscopic retrograde cholangiopancreatography in patients with post-liver transplant biliary complications: results of a cohort study with long-term follow-upClaudia Sanna, Chiara Giordanino, Ilaria Giono, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis deltaGrazia Anna Niro, Alessia Ciancio, Giovanni Battista Gaeta, et al.
Pageof 20